EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticity

Linshan Liu1,2, Ellie J Massey1,2, Dongmei Zuo2

  • 1Department of Biochemistry, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.

EMBO Reports
|January 28, 2026
PubMed

Insights

Enhancer of Zeste Homolog 2 (EZH2) drives aggressive HER2+ breast cancer progression and metastasis. Inhibiting EZH2 increases estrogen receptor expression, making tumors sensitive to endocrine therapies like Tamoxifen.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • HER2-positive (HER2+) breast cancer is aggressive and develops resistance to targeted therapies.
  • Enhancer of Zeste Homolog 2 (EZH2) regulates gene expression critical for cell function.
  • EZH2's role in HER2+ breast cancer progression and therapy resistance is not fully understood.

Purpose of the Study:

  • To investigate the role of EZH2 in HER2+ breast cancer initiation and metastasis.
  • To determine how EZH2 influences cellular plasticity and gene expression in HER2+ tumors.
  • To evaluate the therapeutic potential of combining EZH2 inhibition with endocrine therapy.

Main Methods:

  • Utilized a genetically engineered mouse model of HER2+ breast cancer with conditional Ezh2 knockout.
  • Performed bulk and single-cell RNA sequencing to analyze gene expression changes.
  • Investigated EZH2 inhibition effects on HER2+ human breast cancer cell lines in vitro.

Main Results:

  • Ezh2 deficiency accelerated tumor initiation and metastatic dissemination in mice.
  • Loss of Ezh2 led to decreased basal cell populations and increased luminal progenitor populations, involving Esr1.
  • In vitro EZH2 inhibition increased estrogen receptor (ER) expression and tamoxifen sensitivity in HER2+ cells.

Conclusions:

  • EZH2 plays a critical role in driving cancer cell plasticity in HER2+ breast cancer.
  • Targeting EZH2 may overcome resistance to HER2-targeted therapies.
  • Combining EZH2 inhibitors with endocrine therapies offers a promising strategy to improve treatment outcomes for HER2+ breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Plasticity00:58

Plasticity

Plasticity is the property where an object loses its elasticity and undergoes irreversible deformation, even after the deformation forces are eliminated. If a material deforms irreversibly without increasing stress or load, then this is called ideal plasticity. For example, when a force is applied to an aluminum rod, it changes its shape, but it does not return to its original shape once the force is removed. Plastic deformation or ductility is thus a permanent deformation or change in the...
3.1K
Plasticizers01:31

Plasticizers

Water-reducers, or plasticizers, are chemical admixtures used in concrete to improve strength and workability. These additives reduce the water-cement ratio without compromising workability, lower the cement content while maintaining the same workability, or increase workability to assist concrete placement in inaccessible areas.
Plasticizers function by using surface-active agents to create repulsive electrostatic forces between cement particles. This dispersion enhances the concrete's...
366
Plastic Behavior01:21

Plastic Behavior

A material's elastic behavior is characterized by the disappearance of stress once the load is removed, allowing the material to return to its original state. However, when stress surpasses the yield point, yielding commences, marking the onset of plastic deformation or permanent set. This change from elastic to plastic behavior is influenced by the peak stress value and the duration before the load is removed. An intriguing observation occurs when a specimen is loaded, unloaded, and...
569
Plastic Deformations01:14

Plastic Deformations

It is essential to understand how structural members behave under plastic deformation when the bending stress exceeds the material's yield strength. This state of deformation permanently alters the shape of the member, in contrast to the linear elastic behavior observed before yielding. The strain at any point in the member is expressed in terms of maximum strain. Notably, the neutral axis, which coincides with the centroid during elastic bending, shifts away from the centroid under plastic...
431
Plastic Deformations01:19

Plastic Deformations

Plastic deformation represents a fundamental concept in materials science, which explains the irreversible change in the shape of a material when it experiences stress beyond its elastic capability. This phenomenon is important in structural engineering, especially in designing and analyzing cantilever beams—structures that are securely fixed at one end and bear loads at the opposite end. When these beams are subjected to loads within their elastic range, they will return to their...
459